Physician profile
Debra Berry
NPI 1104119767
$3,073.97
in general payments reported to CMS, 2019-2025
16 companies · $591 in 2025
The $591 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.13 · 2022: $440 · 2023: $1,162 · 2024: $820 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,572.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $777.15 | 2022-2025 | Andexxa, Fasenra |
| Abiomed | $564.77 | 2023-2025 | Impella |
| Boston Scientific Corporation | $235.22 | 2024-2025 | Axonics |
| Abbvie INC. | $220.25 | 2022-2023 | |
| Lilly USA, LLC | $188.21 | 2024-2025 | Kisunla, Zepbound |
| Inari Medical, INC. | $147.24 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Neurocrine Biosciences, INC. | $136.25 | 2023 | Ingrezza |
| Glaxosmithkline, LLC. | $122.92 | 2025 | Nucala |
| Eisai INC. | $122.07 | 2024 | |
| Tris Pharma INC | $121.66 | 2023 | Quillichew Er, Quillivant, Dyanavel Xr |
| Baxter Healthcare | $121.45 | 2024 | Starling System |
| Bayer Healthcare Pharmaceuticals INC. | $102.40 | 2022 | |
| Amgen INC. | $91.72 | 2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $61.53 | 2025 | |
| Axonics, INC. | $45.06 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.